Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)
NCT ID: NCT03791606
Last Updated: 2019-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
755 participants
OBSERVATIONAL
2012-01-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI (PRECISE)
NCT07020130
Predictors of Contrast-induced Acute Renal Injury in Patients With Acute Coronary Syndrome
NCT07294911
Follow-up of Long-term Renal Function After Acute Kidney Injury in ICU
NCT03302624
Mehran 2.0 Risk Score for Prediction of CA-AKI After PCI
NCT05132062
Acute Kidney Injury in Intensive Care Patients
NCT05970952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* lactation
* end-stage renal disease (eGFR \<15 mL/min/1.73 m2)
* long-term dialysis treatment
* intravascular administration of contrast medium within the last 7 or 3 days postoperatively
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiyang Lin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kaiyang Lin
Fujian Provincial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fujian Provincial
Fuzhou, Fujian, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KLin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.